The Therapeutic Goods Administration issued the company seven infringement notices totaling $93,240 for promoting its nasal spray, Viraleze, via its website and YouTube channel.
Starpharma issued a statement on Monday, and said the company"immediately acted" after they found out.
Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:
While most would find such a fine nothing to sneeze at, a global company would probably thumb their nose at the idea of it being a problem.